Advertisement
Singapore markets open in 8 hours 46 minutes

  • Straits Times Index

    3,300.04
    -3.15 (-0.10%)
     

  • S&P 500

    5,196.09
    +15.35 (+0.30%)
     

  • Dow

    38,906.66
    +54.39 (+0.14%)
     

  • Nasdaq

    16,392.11
    +42.86 (+0.26%)
     

  • Bitcoin USD

    63,830.80
    +234.63 (+0.37%)
     

  • CMC Crypto 200

    1,321.24
    -43.88 (-3.21%)
     

  • FTSE 100

    8,313.67
    +100.18 (+1.22%)
     

  • Gold

    2,321.40
    -9.80 (-0.42%)
     

  • Crude Oil

    78.50
    +0.02 (+0.03%)
     

  • 10-Yr Bond

    4.4250
    -0.0640 (-1.43%)
     

  • Nikkei

    38,835.10
    +599.03 (+1.57%)
     

  • Hang Seng

    18,479.37
    -98.93 (-0.53%)
     

  • FTSE Bursa Malaysia

    1,605.68
    +8.29 (+0.52%)
     

  • Jakarta Composite Index

    7,123.61
    -12.28 (-0.17%)
     

  • PSE Index

    6,618.58
    -33.91 (-0.51%)
     

Want Growing Passive Income? Consider Buying This Stock

Kody Kester, The Motley Fool
·3-min read
Want Growing Passive Income? Consider Buying This Stock

As one of the largest diagnostic companies in the United States, Quest Diagnostics (NYSE: DGX) is vitally important to the healthcare sector. Prior to the pandemic, Quest Diagnostics was already an impressive company, serving 1-in-3 American adults and half of the hospitals in the U.S. Thanks to its commitment to innovation, the company was able to quickly respond to the pandemic by launching five different types of COVID-19 tests. This provided a temporary boost to its growth prospects: Full-year revenue surged 14.3% in 2021 to $10.8 billion, and adjusted diluted earnings per share (EPS) soared 27.4% for the year to $14.24.

Continue reading